AJAP1 and neoplasm: In breast cancer cells, AJAP1 has been shown to modulate epithelial growth factor (EGF)-dependent E-cadherin internalization, a process that occurs during tissue remodeling and pathological processes such as tumor development (Gross et al., 2009).